Hepatitis B Virus Reactivation in Lymphoma Patients With Prior Resolved Hepatitis B Undergoing Anticancer Therapy With or Without Rituximab

Yeo, Winnie; Ching Chan, Tung; Leung, Nancy; Yip Lam, Wai; Mo, Frankie; Ting Chu, Miu; Lik‐Yuen Chan, Henry; P. Hui, Edwin; I. K. Lei, Kenny; Mok, Tony; K.S. Chan, Paul

doi:10.1200/jco.2008.18.0182

Public

Hepatitis B Virus Reactivation in Lymphoma Patients With Prior Resolved Hepatitis B Undergoing Anticancer Therapy With or Without Rituximab

Published in Journal of Clinical Oncology • Dec 16, 2008

Authors:

Winnie Yeo

Tung Ching Chan

Nancy Leung

Abstract

PURPOSE: Reactivation of hepatitis B virus (HBV) infection is a well-recognized complication in cancer patients with chronic HBV (hepatitis B surface antigen [HBsAg] positive) undergoing cytotoxic chemotherapy. In patients who have resolved HBV (HBsAg negative and antibody to hepatitis B core antige...

Subject

Medicine

Rituximab

HBsAg

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!